Blog

Obsidian Therapeutics Presents Data Demonstrating Regulation of Protein Activity with its Next-Generation CAR-T … – Business Wire (press release)


Business Wire (press release)

Obsidian Therapeutics Presents Data Demonstrating Regulation of Protein Activity with its Next-Generation CART
Business Wire (press release)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced the presentation of preclinical data

and more »

2018-02-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.